Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

  • Price (USD)32.35
  • Today's Change-1.37 / -4.06%
  • Shares traded687.50k
  • 1 Year change16.16%
  • Beta0.6436
Data delayed at least 15 minutes, as of Feb 25 2020 21:00 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.

  • Revenue in USD (TTM)3.07bn
  • Net income in USD-201.36m
  • Incorporated2005
  • Employees28.60k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttp://www.acadiahealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Magellan Health Inc7.20bn7.69m1.72bn10.50k265.161.2612.180.23910.26540.2514292.8355.682.33152.128.68685,848.700.24832.560.3583.862.404.250.10671.161.652.360.3390.0025.2715.58-75.97-27.831.13--
BioTelemetry Inc430.68m38.66m1.73bn1.50k47.964.8021.914.021.061.0611.8510.620.688921.409.24287,117.306.186.406.797.3962.3060.698.986.762.356.900.35250.0039.3025.27641.48--24.70--
Diversified Healthcare Trust1.07bn-155.08m1.84bn600.00--0.65313.011.72-0.6528-0.65284.5011.870.1488----1,782,230.00-2.082.59-2.142.6355.1261.38-14.0017.09--0.82380.5519205.723.957.9794.349.32-1.020.00
HMS Holdings Corp626.40m87.22m2.11bn2.50k24.232.4715.363.370.98930.98937.109.700.5394--2.91--7.514.738.215.2334.7531.3013.928.46----0.2192--4.707.1658.6244.29-3.77--
Irhythm Technologies Inc198.60m-51.98m2.31bn748.00--16.14--11.63-2.09-,512.00-24.23-34.91-28.77-41.8475.2869.42-26.17-37.323.99-27.090.1968--49.5257.15-64.11--62.87--
Progyny Inc193.75m-5.80m2.44bn137.00------12.61-0.0706-0.072.360.1824------1,549,984.00--------20.21---2.97----35.470.00--116.94--15.99------
Agape ATP Corp1.37m-481.83k2.45bn----546.06--1,788.60-0.0013-0.00130.00360.01190.2705--4.26---9.53---10.21--7.22---35.24-----7.780.00--217.46---298.89------
Livongo Health Inc140.81m-61.60m2.56bn576.00--5.11--18.20-0.6775-0.67751.555.31------365,742.80--------70.09---43.59--10.98--0.00--121.82---97.31------
The Ensign Group, Inc.2.04bn91.69m2.61bn24.50k29.814.0418.231.281.641.9736.3812.091.15--6.9683,123.435.205.156.326.5120.4216.804.533.35--10.080.333216.2216.0714.6654.1220.5928.176.30
1life Healthcare Inc256.91m-51.56m2.73bn1.60k------10.62-0.4212-0.42122.101.87------191,583.90--------39.93---20.55--2.97--0.0185--20.31---44.22------
Option Care Health Inc1.77bn-78.43m2.87bn1.66k--3.10--1.62-0.9456-0.945118.515.231.1220.767.881,070,130.00-4.78-20.26-5.50-25.6022.5329.43-4.26-15.421.36-0.22110.5788---13.250.354455.49---11.53--
Myokardia Inc12.40m-233.12m2.95bn220.00--6.53--238.10-5.22-5.220.28689.790.0269----75,151.52-50.54-20.49-55.91-24.65-645.16---1,880.02-163.29----0.00--193.29---18.75--23.61--
Acadia Healthcare Company Inc3.07bn-201.36m2.99bn28.60k--1.22--0.9726-2.31-2.4235.0127.620.4632--8.83107,369.80-3.030.893-3.260.9566-----6.551.771.162.080.5680.006.2133.39-198.06--36.11--
NeoGenomics, Inc.378.44m2.06m3.16bn1.50k1,727.336.35140.538.350.01750.01753.774.770.64919.984.92252,291.300.3538-0.59870.3928-0.680748.6344.010.5451-0.88724.054.400.1799--15.1933.01143.6624.5348.06--
Tenet Healthcare Corp18.29bn-250.00m3.40bn90.09k----3.600.1857-2.42-2.31176.96-3.290.80199.746.57203,041.400.50850.68160.7040.93783.5483.970.63420.80561.141.940.8844---4.5210.53123.58---2.24--
Select Medical Holdings Corporation5.45bn143.45m3.69bn35.70k24.884.788.910.67581.101.1041.895.740.8199--7.42152,770.903.
Data as of Feb 25 2020. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

74.00%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 201913.76m15.54%
Wellington Management Co. LLPas of 31 Dec 201911.71m13.22%
The Vanguard Group, Inc.as of 31 Dec 20198.24m9.30%
BlackRock Fund Advisorsas of 31 Dec 20197.43m8.39%
Dimensional Fund Advisors LPas of 31 Dec 20196.16m6.96%
P2 Capital Partners LLCas of 31 Dec 20195.58m6.30%
Elliott Management Corp.as of 31 Dec 20194.35m4.91%
JPMorgan Investment Management, Inc.as of 31 Dec 20193.73m4.21%
Abrams Bison Investments LLCas of 31 Dec 20192.39m2.70%
SSgA Funds Management, Inc.as of 31 Dec 20192.20m2.49%
More ▼
Data from 31 Dec 2019 - 31 Dec 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.